Inato

AI-powered patient pre-screening with EHR and CTMS integration helps clinical sites accelerate enrollment reduce burden, and showcase patient data insights that drive trial success.

Streamline your site strategy to enable faster, data-driven selection of the right sites for every trial.

Research sites can shape their trial pipeline, highlight strengths, and apply for studies with top sponsors while reducing administrative burden.

Inato’s AI-powered platform connects sponsors with engaged research sites to accelerate drug development and patient care.

Inato and Sanofi collaborate to use real-time patient access data for feasibility planning and cross-asset enrollment across clinical trials.

Inato co-founders sat down for a transparent conversation with Brad Hightower to explore Inato’s mission, better understand how the platform works to benefit sites, and debut a live product demo.

Insights, industry voices, and site spotlights from Inato on clinical trial enrollment, patient pre-screening, site engagement, and trial diversity.

Real-world results from Inato-supported clinical trials — see how sponsors accelerated enrollment, hit recruitment targets, and reached diverse patients.

Inato shares news, press releases, partnerships, and media coverage on clinical trial recruitment, diversity, and site enablement.

Inato seeks talent to advance its mission of making clinical trials accessible to all patients globally.

Bringing life-changing trials to every patient, everywhere.

Inato unites sponsors, research sites, and patients through one AI-powered platform, expanding access, increasing efficiency, and bringing life-changing treatments to more communities around the world.

Inato’s website, marketplace, and clinical trial platform are governed by specific terms and conditions.

Inato teams up with RealTime eClinical Solutions to enhance trial site selection and participant enrollment processes. The collaboration focuses on streamlining clinical trial operations for improved efficiency. Both companies specialize in digital solutions for healthcare research.

Sep 2025Yahoo FinanceNews article

Inato introduces an AI-powered site selection tool that accelerates decision-making using verified data. The platform aggregates insights from over 5,500 research sites worldwide to support strategic planning. Users rely on real-time engagement metrics and validated datasets for precision in site choices.

Sep 2025PR NewswireNews article

Inato introduces AI-powered tools to streamline clinical trial site selection. The platform enables sponsors to generate and run data-driven site selection scenarios using real-time interest data and verified information from over 5,500 sites. This aims to improve efficiency and decision-making in clinical trial planning.

Sep 2025hitconsultant.netNews article

Inato raises **$20 million in Series A2 funding** to expand its platform for inclusive clinical trials. The round includes return investors Cathay Innovation and Obvious Ventures, alongside new backers La Maison and Top Harvest Capital. The funding supports Inato’s mission to improve accessibility in clinical research by leveraging technology.

Mar 2023Pulse 2.0News article